Agenda: Seattle’s Life Science Disruptors

5.2.2016 AGENDA
12:30  1:30Registration & Networking
1:30  1:40Welcome
Nicole Robinson, Fred Hutchinson Cancer Research Center
Jim Edwards, Xconomy
1:40  2:00Update From The Immuno-Oncology Trenches
Rob Hershberg, Celgene
2:00  2:15CD19 CAR-T Cell Immunotherapy: A Case Study
Cameron Turtle
, Fred Hutchinson Cancer Research Center
2:15  2:30Immunotherapy Beyond Cancer
Andrew Scharenberg
, Seattle Children’s Research Institute
2:30  2:55Wellness and Prevention, 21st Century Priorities
Clayton Lewis, Arivale
Molly Moore, Cambia Health Solutions
Alex Lash, Xconomy (moderator)
2:55  3:25From AIDS To Zika, Combating Global Health Crises
Jennifer Dent, BIO Ventures for Global Health
Larry Corey, HIV Vaccine Trials Network, Fred Hutchinson Cancer Research Center
Jim Thomas, Just Biotherapeutics
Rhea Coler, Infectious Disease Research Institute
3:25  4:00Networking Break
4:00 – 4:25Sharing Data For Better Health
Stephen Friend, Sage Bionetworks
Matthew Trunnell, Fred Hutchinson Cancer Research Center
Panel Moderated by:
Austin Walsh, IBM
4:25 – 4:40The State Of Seattle Startups
Thong Le
, Accelerator
In conversation with Alex Lash, Xconomy
4:40 – 5:00M3 Biotechnology: A Founder-Investor Story
Leen Kawas
, M3 Biotechnology
John Fluke, Fluke Capital Management
Alex Lash, Xconomy (moderator)

5:00 – 5:30Proteins Like You’ve Never Seen
David Baker, University of Washington
Aaron Chevalier, Virvio
Lucas Nivon, Cyrus Biotechnology
Ingrid Swanson Pultz, PVP Biologics
Alex Lash, Xconomy (moderator)
5:30 – 6:30Networking Reception